Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025 Biotech Investing
Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference Biotech Investing
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth Pharmaceutical Investing
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET Biotech Investing
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program Biotech Investing
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Biotech Investing
Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System Biotech Investing
BioRestorative Awarded Notice of Allowance for Japanese Patent - Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market Biotech Investing
Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting Biotech Investing
Nextech3D.ai Reports Strong 20% Q2 Sequential Revenue Growth With Gross Margins of 88% For the Three Months Ended September 30, 2025 ("Q2 2026")
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
